At a glance
ClinicalIndex Comparison RecordN/ACompleted· 53 enrolled
Drug / intervention
Avena Sativa Skincare Regimenother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Center, Clinical Study to Determine the Safety and Efficacy of an Avena Sativa Skincare Regimen for Therapy-Related Pruritus and Xerosis in Cancer Patients
In Brief
A clinical study evaluating Avena Sativa Skincare Regimen for Ichthyosis and Pruritus. Completed, enrolled 53 participants across 1 site.
Detailed Summary
This study will test the safety and efficacy of three topical agents containing oat kernel flour to determine how well they relieve skin dryness and itching related to cancer therapies. Participants will receive a body wash, a body cream, and an anti-itch balm to use at home for 4-6 weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIchthyosis, Pruritus
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 2019
Enrollment StartMay 2019
Primary CompletionDec 2019
TodayJul 2026
First PostedJan 8, 2019
Enrollment StartMay 23, 2019
Primary CompletionDec 18, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.5 years ago
Interventions
Avena Sativa Skincare Regimenother
Regimen consisting of 3 topical agents containing Avena Sativa (oat) kernel flour: a body wash (type = cosmetic), a body cream (type = cosmetic), and an anti-itch balm (type = OTC monograph drug with 0.5% Pramoxine HCl)